web analytics

Initiator Pharma receives commitment of support for IPED2015 from Innovation Fund Denmark

Initiator Pharma A/S, a biotech company that is developing a novel treatment of erectile dysfunction, today announced that they have received a commitment from Innovation Fund Denmark to support the on-going clinical development of IPED2015.
The Innobooster grant will support the ongoing trial with up to 2 MDKK. 

‘We are delighted to receive a commitment of support from Innovation Fund Denmark through the Innobooster program. It is a clear validation of Initiator Pharma and the quality of our IPED2015 program. We remain confident that IPED2015 will be a breakthrough therapy for the PDE5i

Source: Initiator Pharma receives commitment of support for IPED2015 from Innovation Fund Denmark

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.